JDRF Chairman, D.Phil student at Keble College. It was a great honour to become Chairman of JDRF 30 years after I played a small part, as a lawyer at Slaughter and May, in its incorporation. I was diagnosed with type 1 three years later and joined the Board in 2013, when I retired from the firm, who are still our legal advisers. There have been, and continue to be, great advances in the treatment of type 1 and JDRF has a proud record of supporting the research that plays such a vital part. Type 1 nevertheless remains a chronic and as yet incurable condition, with irritating and restricting lifestyle adjustments as well as the risk of serious complications, both in the short and long term - and however well blood glucose levels are managed. A cure would offer relief not only to those of us with the condition but also to our families from the stresses and strains that accompany living, directly or indirectly, with the condition.
JDRF Treasurer, Executive Committee Member, Partner at PwC with a focus on Distressed Financial Restructuring, and a Chartered Accountant. I have type 1 diabetes and was diagnosed over 40 years ago. I am now starting to confront some of the wider medical issues arising from having had type 1 for an extended period and realistically, given my age, I don't see a personal benefit from a type 1 cure. However I feel very passionate about achieving a cure so that others do not have to deal with managing that delicate blood sugar level balance, or cope with the consequences when it goes wrong. This extends beyond those who have type 1 to all those who love and live with them. If we can put a man on the moon...
Chief Executive Officer of Aon Benfield, JDRF Board Director - My daughter Julia was diagnosed with type 1 aged just four years old on 14 January 2002. My family and I choose to support JDRF because of its focus on type 1 medical research and its commitment to drive and deliver improvements in treatment until we find the cure for type 1 diabetes. I believe the JDRF global research programme is the best hope for the cure and for a future for Julia without type 1. I do all I can personally and professionally to help JDRF, and I am proud to be a member of the Board.
International banker with corporate finance and private banking experience; JDRF Board Director and Director of JDRF Trading Ltd. One of my daughters, Alexandra, has lived with type 1 diabetes for many years. Following her diagnosis our family wanted to learn as much as possible about the condition and contribute in some way to finding the cure which is why we got in touch with JDRF. This is the second term I have served on the Board and it's exciting to see how much JDRF as an organisation has developed and the great strides that have been made within research that will help cure, treat and prevent type 1. It's a hugely exciting time to be part of JDRF's work and I am honoured to have been asked to serve a second term.
Managing Director, Corporate Strategic Initiatives PMO at BNY Mellon. JDRF Board Director - Both my niece and nephew were diagnosed with type 1 diabetes in their teenage years and I saw at close hand the dramatic effect this had on their lives and that of my sister. A cure would mean a world free of constant worry for all who have to manage this chronic and life-changing condition. I choose to support JDRF because of its laser-like focus and commitment to finding the cure and am honoured to sit on its board.
James M Lurie
Corporate Attorney and Partner at Wollmuth Maher & Deutsch, JDRF Board Director - My brother and niece both have type 1 diabetes. The cure would be a dream come true for our family, the completion of a sacred promise I made to my brother and parents that I wouldn’t stop until a cure is found. Not to have to worry about complications, about daily shots and blood testing. To see the smile on my niece’s face that she no longer has to worry about any of these things. But what will be the cure? What ‘cures’ my brother and niece and others with type 1 diabetes may necessitate different remedies and then how do we be make sure that my and my brother’s grandchildren don’t become afflicted with type 1 diabetes? The research must go on. We need your help. There is a cure out there and together we can and will find it.
My connection to type 1 is that my daughter Sarah was diagnosed 22 years ago at the age of 11. This was a life changing moment for the whole family and type 1 has been a significant influence on our lives ever since, bringing some bad times but also a lot of inner strength to all of us. I was introduced to JDRF by a business connection way back in 2002 and was very proud to serve on the Board from then until 2008. After that I became Chair of the Trading Company until I was asked to re-join the Board this year, which of course I agreed to with great pleasure. I love JDRF for what it does, for the purity of its mission, and for the terrific team, led by the extraordinary and inspiring CEO, Karen. A cure would of course remove the daily anxiety that we live with, but we have come to terms with it in our lives and really my vision is for the future - when I know we will rid the world of this cruel and terribly misunderstood condition. Being part of that mission is deeply important to me and to all of us. In my business life, I am an electronics engineer by training and have been deeply involved in building advanced technology manufacturing businesses for most of my career. I have my own Change Management company, but at the moment I am fully engaged as Chief Operating Officer of ZapGo Ltd, an Oxford based early-stage scientific business developing next generation energy storage technologies.
Editorial Director of The Sunday Times and Chair of Women in Journalism - My twin god-daughters have type 1 and a childhood friend died from its complications so the science of how we can make life safer and easier for those who have the condition has long been a passion of mine. I am dedicated to working with JDRF and am proud to be putting my professional, political and social contacts to good use in order to raise awareness of type 1 and ultimately find the cure.